Quick Answer
Bausch Health Companies Inc. reported Cash and Equivalents of $1.31 billion for fiscal year 2025.
Bausch Health Companies Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.31B | +10.8% |
| 2024 | $1.18B | +24.7% |
| 2023 | $947.00M | +67.9% |
| 2022 | $564.00M | -3.1% |
| 2021 | $582.00M | -3.8% |
| 2020 | $605.00M | -81.3% |
| 2019 | $3.24B | +349.8% |
| 2018 | $721.00M | +0.1% |
| 2017 | $720.00M | +32.8% |
| 2016 | $542.00M | -9.2% |
| 2015 | $597.00M | +84.8% |
| 2014 | $323.00M | -46.2% |
| 2013 | $600.00M | -34.5% |
| 2012 | $916.10M | +458.3% |
| 2011 | $164.10M | -58.4% |
| 2010 | $394.27M | +244.5% |
| 2009 | $114.46M | -64.0% |
| 2008 | $317.55M | -26.8% |
| 2007 | $433.64M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.31B | +81.9% | -24.3% |
| June 30, 2025 | $1.73B | +190.3% | +52.3% |
| March 31, 2025 | $1.13B | +54.7% | -4.0% |
| December 31, 2024 | $1.18B | +24.7% | +64.3% |
| September 30, 2024 | $719.00M | -5.4% | +20.8% |
| June 30, 2024 | $595.00M | +2.8% | -18.8% |
| March 31, 2024 | $733.00M | +41.5% | -22.6% |
| December 31, 2023 | $947.00M | +67.9% | +24.6% |
- Bausch Health Companies Inc. showed an increase of +10.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, Bausch Health Companies Inc.’s cash and equivalents has grown by 201.9% (from $433.64 million to $1.31 billion).
- The most recent figure is from Bausch Health Companies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: